72.19.Z - Other research and experimental development on natural sciences and engineering
32.50.Z - Manufacture of medical and dental instruments and supplies
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 493,7 | 449,2 | 445,7 | -0,8 |
Gross profit (loss) | 64,2 | -51,9 | 5,4 | 110,5 |
Net profit (loss) | 64,2 | -51,9 | 5,4 | 110,5 |
Cash | 27,8 | 1,2 | 10,6 | 821,3 |
Net income from sale | 287,5 | 71,6 | 39,8 | -44,4 |
Liabilities and provisions for liabilities | 20,9 | 35,7 | 26,8 | -25,1 |
Short time liabilities | 19,9 | 9,5 | 0,6 | -94,2 |
Working assets | 487,8 | 447,7 | 445,7 | -0,5 |
Equity capital | 472,8 | 413,4 | 418,9 | 1,3 |
Operating profit (EBIT) | 64,2 | -51,9 | 5,4 | 110,5 |
% | % | % | p.p. | |
Equity capital to total assets | 95,8 | 92 | 94 | 2 |
Gross profit margin | 22,3 | -72,4 | 13,7 | 86,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 25 | 49 | 5 | -44 |
Current financial liquidity indicator | 24.454565048217773 | 46.91264724731445 | 800.1240234375 | 753,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane